298 related articles for article (PubMed ID: 6201693)
1. [Tumor markers in focal and diffuse liver diseases].
Kasatkin IuN; Ametov AS; Mit'kov VV; Sevast'ianov SI; Zarudin VV
Med Radiol (Mosk); 1984 Apr; 29(4):39-43. PubMed ID: 6201693
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of liver diseases using serum biomarkers.
Cujic D; Golubovic S; Bojic-Trbojevic Z; Ilic N; Baricevic I; Nedic O
J BUON; 2010; 15(1):141-6. PubMed ID: 20414942
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunological determination of the level of serum ferritin in liver diseases].
Mitkov VV; Kasatkin IuI; Ametov AS; Larina IM; Toritsina LK
Med Radiol (Mosk); 1983 Apr; 28(4):62-5. PubMed ID: 6835075
[TBL] [Abstract][Full Text] [Related]
4. [Serum ferritin in patients with malignant neoplasms].
Hoshi H; Nakayama S; Kodama T; Jinnouchi S; Nishikawa K; Wakuta Y; Kakitsubata Y; Kusuhara T; Watanabe K
Radioisotopes; 1983 Jan; 32(1):13-7. PubMed ID: 6190199
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
Weber P; Weberová D; Martínek K
Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective study of the serum CEA, AFP, TPA and ferritin values in 500 patients with chronic liver diseases].
Cioffi M; Fratta M; De Lucia D; Bresciani F
Arch Monaldi Mal Torace; 1990; 45(3):159-65. PubMed ID: 1726999
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunological determination of tumor markers in the diagnosis of recurrences of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1991; 36(10):17-20. PubMed ID: 1719331
[TBL] [Abstract][Full Text] [Related]
9. [Serum ferritin in patients with hepatobiliary diseases (author's transl)].
Uchiyama Y; Kanazawa S; Okuda K
Rinsho Ketsueki; 1980 Aug; 21(8):1104-11. PubMed ID: 6160268
[No Abstract] [Full Text] [Related]
10. Differential tumor markers and hepatitis markers profile in liver tumors.
Khalifa A; Mady EA; Abadeer N; Kamal A
Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
[TBL] [Abstract][Full Text] [Related]
11. [Carbohydrate antigen (CA-19-9) in the blood serum of patients with benign and malignant liver diseases].
Ametov AS; Kasatkin IuN; Mit'kov VV; Gur'eva IV
Med Radiol (Mosk); 1985 Mar; 30(3):39-41. PubMed ID: 3856723
[TBL] [Abstract][Full Text] [Related]
12. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
13. [Tumor antigens in the diagnosis of gastroenterological diseases (author's transl)].
Lehmann FG
Leber Magen Darm; 1975 Aug; 5(4):144-58. PubMed ID: 57561
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
Toyama K; Noto M; Sakaguchi T; Adachi K; Mitomi H; Okada N; Ootaka H; Nakazawa H; Hara E
Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha-fetoprotein subfractions identified by Ricinus communis agglutinin I in hepatic malignancies, yolk sac tumor, benign hepatic diseases, and fetal stage.
Ishiguro T; Takahashi Y
Dis Markers; 1989; 7(4):239-45. PubMed ID: 2479498
[TBL] [Abstract][Full Text] [Related]
17. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
18. [Significance of the carcinoembryonic antigen (CEA) in the diagnosis of hepatopathies].
Fiaccadori F; De Simoni M; Ghinelli F; Magnani G; Pelosi G; Salvadori C
Minerva Med; 1981 Jul; 72(28):1847-54. PubMed ID: 7254632
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
Zuberi SJ; Lodi TZ; Nazli A
J Pak Med Assoc; 1977 Jun; 27(6):348-50. PubMed ID: 74425
[No Abstract] [Full Text] [Related]
20. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
